The role of chemotherapy in the management of mesothelioma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

44.6 Conclusions: Several chemotherapy agents have shown minor activity in MPM. Most of the studies supporting their use as single agents or in combination are misleading because of the sample size, lack of uniform measures of response, and lack of reproducibility. However, the combination of cisplatin with pemetrexed has demonstrated improved survival in phase III studies and is now considered standard therapy for mesothelioma.

Original languageEnglish (US)
Title of host publicationTumors of the Chest
Subtitle of host publicationBiology, Diagnosis and Management
PublisherSpringer Berlin Heidelberg
Pages515-524
Number of pages10
ISBN (Print)6293603618, 9783540310396
DOIs
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The role of chemotherapy in the management of mesothelioma'. Together they form a unique fingerprint.

  • Cite this

    Molina, J. R., & Adjei, A. A. (2006). The role of chemotherapy in the management of mesothelioma. In Tumors of the Chest: Biology, Diagnosis and Management (pp. 515-524). Springer Berlin Heidelberg. https://doi.org/10.1007/3-540-31040-1_44